These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 18625433)

  • 21. Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics.
    Shariff MI; Cox IJ; Gomaa AI; Khan SA; Gedroyc W; Taylor-Robinson SD
    Expert Rev Gastroenterol Hepatol; 2009 Aug; 3(4):353-67. PubMed ID: 19673623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatocellular carcinoma and non-Hodgkin's lymphoma: the roles of HIV, hepatitis C infection, and alcohol abuse.
    McGinnis KA; Fultz SL; Skanderson M; Conigliaro J; Bryant K; Justice AC
    J Clin Oncol; 2006 Nov; 24(31):5005-9. PubMed ID: 17075119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The epidemiology of hepatocellular carcinoma.
    Johnson PJ
    Eur J Gastroenterol Hepatol; 1996 Sep; 8(9):845-9. PubMed ID: 8889448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [From hepatitis to hepatocellular carcinoma].
    Omata M
    Gan To Kagaku Ryoho; 1994 Aug; 21(10):1559-64. PubMed ID: 8060128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The progression of hepatitis B- and C-infections to chronic liver disease and hepatocellular carcinoma: epidemiology and pathogenesis.
    Hayashi PH; Di Bisceglie AM
    Med Clin North Am; 2005 Mar; 89(2):371-89. PubMed ID: 15656931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Alcoholic liver diseases and hepatitis virus C in Japan].
    Horie Y; Yamagishi Y; Kato S; Kikuchi M; Ishii H; Hibi T
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2006 Oct; 41(5):424-30. PubMed ID: 17176848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics and outcome of patients with dual hepatitis B and C-associated hepatocellular carcinoma: are they different from patients with single virus infection?
    Huo TI; Huang YH; Hsia CY; Su CW; Lin HC; Hsu CY; Lee PC; Lui WY; Loong CC; Chiang JH; Chiou YY; Lee SD
    Liver Int; 2009 May; 29(5):767-73. PubMed ID: 19018974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathobiologic effects of hepatitis C.
    Gerber MA
    J Hepatol; 1995; 22(1 Suppl):83-6. PubMed ID: 7602083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence and risk factors of hepatocellular carcinoma in patients with primary biliary cirrhosis.
    Macaron C; Hanouneh IA; Zein NN
    Hepatology; 2010 Dec; 52(6):2239; author reply 2239-40. PubMed ID: 21105115
    [No Abstract]   [Full Text] [Related]  

  • 30. Etiology of hepatocellular carcinoma in Argentina: results of a multicenter retrospective study.
    Fassio E; Míguez C; Soria S; Palazzo F; Gadano A; Adrover R; Landeira G; Fernández N; García D; Barbero R; Perelstein G; Ríos B; Isla R; Civetta E; Pérez Ravier R; Barzola S; Curciarello J; Colombato LA; Jmeniltzky A
    Acta Gastroenterol Latinoam; 2009 Mar; 39(1):47-52. PubMed ID: 19408739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatocellular carcinoma, a rapidly increasing public health problem: the Tulane experience 2003-2009.
    Tangutur NK; Medvedev SF; Regenstein F; Balart LA
    J La State Med Soc; 2011; 163(4):185-90. PubMed ID: 21954650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for hepatocellular carcinoma in a Japanese population: a nested case-control study.
    Ohishi W; Fujiwara S; Cologne JB; Suzuki G; Akahoshi M; Nishi N; Takahashi I; Chayama K
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):846-54. PubMed ID: 18398026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Epidemiology of malignant liver tumors].
    Rodella S; Picoco C
    Ann Ist Super Sanita; 1996; 32(4):595-610. PubMed ID: 9382428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Risk factors of liver tumors].
    Fehér J; Lengyel G
    Orv Hetil; 2004 Feb; 145(7 Suppl 1):365-7. PubMed ID: 15049052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for hepatocellular carcinoma in HCV-cirrhosis: what we know and what is missing.
    Fattovich G; Llovet JM
    J Hepatol; 2006 Jun; 44(6):1013-6. PubMed ID: 16678654
    [No Abstract]   [Full Text] [Related]  

  • 36. Epidemiology of hepatocellular carcinoma in Japan and Korea. A review.
    Kim SR; Kudo M; Hino O; Han KH; Chung YH; Lee HS;
    Oncology; 2008; 75 Suppl 1():13-6. PubMed ID: 19092267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [High risk group of patients with hepatitis C virus infection developing hepatocellular carcinoma].
    Yokosuka O; Omata M
    Nihon Naika Gakkai Zasshi; 1995 Dec; 84(12):1975-9. PubMed ID: 8586916
    [No Abstract]   [Full Text] [Related]  

  • 38. [The epidemiology and etiology of hepatocarcinoma].
    Martínez Cerezo FJ
    Rev Esp Enferm Dig; 1994 Sep; 86(3):665-71. PubMed ID: 7986600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flavonoid intake and liver cancer: a case-control study in Greece.
    Lagiou P; Rossi M; Lagiou A; Tzonou A; La Vecchia C; Trichopoulos D
    Cancer Causes Control; 2008 Oct; 19(8):813-8. PubMed ID: 18350370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology of hepatocellular carcinoma.
    Bosch FX; Ribes J; Cléries R; Díaz M
    Clin Liver Dis; 2005 May; 9(2):191-211, v. PubMed ID: 15831268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.